Piedmont Healthcare Participating in Remdesivir Expanded Access Program
May 15, 2020
May 15, 2020
ATLANTA, Georgia, May 15 -- Piedmont Healthcare issued the following news release:
Piedmont Healthcare is participating in the U.S. Food and Drug Administration's (FDA) expanded access program for the antiviral drug remdesivir, which was granted emergency use authorization on May 1. The investigational drug was shown in a clinical trial to shorten the recovery time in some COVID-19 patients.
The program is available for patients at Piedmont Atlanta Hospital, Piedmont Fa . . .
Piedmont Healthcare is participating in the U.S. Food and Drug Administration's (FDA) expanded access program for the antiviral drug remdesivir, which was granted emergency use authorization on May 1. The investigational drug was shown in a clinical trial to shorten the recovery time in some COVID-19 patients.
The program is available for patients at Piedmont Atlanta Hospital, Piedmont Fa . . .